My view on current and future use of JAK inhibitors for ET, PV, and MF

In this presentation from the 2017 European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, Dr. Martin Griesshammer outlines his view on the current and future use of JAK inhibito... Author: imedex Added: 10/19/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts